At LSI USA this March, one of the medtech industry's premier gatherings of innovators, inves...
At LSI USA this March, one of the medtech industry's premier gatherings of innovators, inves...
We are halfway through 2026, a natural point to pause and take stock. Across our Board ...
A venture-backed European biotechnology company in the respiratory disease space had just cl...
A leading global dermatology company was relying heavily on external CROs and medical writin...
A US-headquartered medical device organisation was preparing to appoint its first VP, Medica...
From Boston to Las Vegas, Nashville to Philadelphia, Q2 2026 saw the Barrington James team o...
Something has shifted on the conference floor. The investors who once sat quietly at the bac...
Life sciences companies are under pressure to move faster while operating with leaner teams,...